{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:56:57Z","timestamp":1772827017246,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine Reports"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.pmedr.2021.101376","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T05:47:05Z","timestamp":1618811225000},"page":"101376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Health care professionals\u2019 preference for a fully liquid, ready-to-use hexavalent vaccine in Spain"],"prefix":"10.1016","volume":"22","author":[{"given":"Inmaculada","family":"Cuesta Esteve","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Fern\u00e1ndez Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"L\u00f3pez Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Menor Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosanna","family":"Parra Vino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Reyero Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luz","family":"Nieto Nevot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Drago Manch\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Luis","family":"L\u00f3pez-Belmonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmedr.2021.101376_b0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00431-018-03314-3","article-title":"Knowledge and practices regarding infant vaccination: results of a survey of French physicians","volume":"178","author":"Bakhache","year":"2019","journal-title":"Eur J Pediatr"},{"issue":"29","key":"10.1016\/j.pmedr.2021.101376_b0010","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1016\/j.vaccine.2009.04.005","article-title":"Pediatric vaccination errors: application of the \u201c5 rights\u201d framework to a national error reporting database","volume":"27","author":"Bundy","year":"2009","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.pmedr.2021.101376_b0015","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1016\/j.vaccine.2015.06.030","article-title":"Assessment of preparation time with fully-liquid versus non-fully liquid paediatric hexavalent vaccines. A time and motion study","volume":"33","author":"De Coster","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.pmedr.2021.101376_b0020","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/S0264-410X(03)00377-3","article-title":"The value of vaccination: a global perspective","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.pmedr.2021.101376_b0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.7883\/yoken.JJID.2017.277","article-title":"A Safety and Immunogenicity Study of a Single Dose of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MEN-ACWY-D) in Healthy Japanese Participants","volume":"71","author":"Fukushima","year":"2018","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.pmedr.2021.101376_b0030","unstructured":"Garc\u00e9s S\u00e1nchez, M., renales toboso, M., Minguell Gonz\u00e1lez, P., 2010. Vaccine controversy: vaccine safety. What do we know and what can we do to avoid mistakes in daily practice? Rev. Primary Care Pediatrician, 12, 129\u2013138."},{"key":"10.1016\/j.pmedr.2021.101376_b0035","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.vaccine.2018.02.107","article-title":"Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children","volume":"36","author":"Hansen","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.pmedr.2021.101376_b0040","unstructured":"Interterritorial Council of the National Health System of Spain. Vaccination Schedule for Risk Groups, childhood population. Ministry Health Gov. Spain, 2018a. Available from: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario-y-coberturas\/docs\/CalendarioVacunacion_GRinfantil.pdf Accessed on: 15June2020."},{"key":"10.1016\/j.pmedr.2021.101376_b0045","unstructured":"Interterritorial Council of the National Health System of Spain. Vaccination Schedule for Risk Groups, adult population. Ministry Health Gov. Spain, 2018b. Available from: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario-y-coberturas\/docs\/CalendarioVacunacion_GRadultos.pdf Accessed on: 15June2020."},{"key":"10.1016\/j.pmedr.2021.101376_b0050","unstructured":"Interterritorial Council of the National Health System of Spain. Vaccination lifetime schedule. Ministry Health Gov. Spain, 2019. Available from: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario-y-coberturas\/calendario\/docs\/CalendarioVacunacion_Todalavida_2019.pdf. Accessed on: 05 June 2020."},{"key":"10.1016\/j.pmedr.2021.101376_b0055","unstructured":"Interterritorial Council of the National Health System of Spain. Vaccination lifetime schedule. Ministry Health Gov. Spain, 2020. Available from: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario-y-coberturas\/docs\/CalendarioVacunacion_Todalavida.pdf Accessed on: 05June2020."},{"key":"10.1016\/j.pmedr.2021.101376_b0060","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s13312-018-1440-z","article-title":"Safety and immunogenicity of two doses of a quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in indian and russian children aged 9 to 17 months","volume":"55","author":"Javadekar","year":"2018","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.pmedr.2021.101376_b0065","article-title":"Comparison of immune responses to two quadrivalent meningococcal conjugate vaccines (CRM197 and diphtheria toxoid) in healthy adults","volume":"34","author":"Kim","year":"2019","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.pmedr.2021.101376_b0070","article-title":"Practice nurse attitudes to infant vaccine presentations in the UK [Abstract presented at 6th Euro Global Summit and Expo on Vaccines & Vaccination]","volume":"6","author":"Laurence","year":"2015","journal-title":"J Vaccines Vaccin"},{"key":"10.1016\/j.pmedr.2021.101376_b0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/pds.4397","article-title":"Meningococcal conjugate vaccine safety surveillance in the Vaccine Safety Datalink using a tree-temporal scan data mining method","volume":"27","author":"Li","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.pmedr.2021.101376_b0080","first-page":"1517","article-title":"What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution?","volume":"9","author":"Lloyd","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.pmedr.2021.101376_b0085","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1016\/j.vaccine.2016.09.003","article-title":"Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine","volume":"34","author":"Robertson","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.pmedr.2021.101376_b0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40272-019-00353-7","article-title":"DTaP-IPV-HepB-Hib vaccine (Hexyon(\u00ae)): an updated review of its use in primary and booster vaccination","volume":"21","author":"Syed","year":"2019","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.pmedr.2021.101376_b0095","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1016\/j.vaccine.2018.10.100","article-title":"Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers","volume":"36","author":"Vesikari","year":"2018","journal-title":"Vaccine"}],"container-title":["Preventive Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335521000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335521000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T15:01:48Z","timestamp":1761922908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211335521000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":19,"alternative-id":["S2211335521000668"],"URL":"https:\/\/doi.org\/10.1016\/j.pmedr.2021.101376","relation":{},"ISSN":["2211-3355"],"issn-type":[{"value":"2211-3355","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health care professionals\u2019 preference for a fully liquid, ready-to-use hexavalent vaccine in Spain","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmedr.2021.101376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101376"}}